{"2410.20132": {"publish_time": "2024-10-26", "title": "On-Site Precise Screening of SARS-CoV-2 Systems Using a Channel-Wise Attention-Based PLS-1D-CNN Model with Limited Infrared Signatures", "paper_summary": "During the early stages of respiratory virus outbreaks, such as severe acute\nrespiratory syndrome coronavirus 2 (SARS-CoV-2), the efficient utilize of\nlimited nasopharyngeal swabs for rapid and accurate screening is crucial for\npublic health. In this study, we present a methodology that integrates\nattenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR)\nwith the adaptive iteratively reweighted penalized least squares (airPLS)\npreprocessing algorithm and a channel-wise attention-based partial least\nsquares one-dimensional convolutional neural network (PLS-1D-CNN) model,\nenabling accurate screening of infected individuals within 10 minutes. Two\ncohorts of nasopharyngeal swab samples, comprising 126 and 112 samples from\nsuspected SARS-CoV-2 Omicron variant cases, were collected at Beijing You'an\nHospital for verification. Given that ATR-FTIR spectra are highly sensitive to\nvariations in experimental conditions, which can affect their quality, we\npropose a biomolecular importance (BMI) evaluation method to assess signal\nquality across different conditions, validated by comparing BMI with PLS-GBM\nand PLS-RF results. For the ATR-FTIR signals in cohort 2, which exhibited a\nhigher BMI, airPLS was utilized for signal preprocessing, followed by the\napplication of the channel-wise attention-based PLS-1D-CNN model for screening.\nThe experimental results demonstrate that our model outperforms recently\nreported methods in the field of respiratory virus spectrum detection,\nachieving a recognition screening accuracy of 96.48%, a sensitivity of 96.24%,\na specificity of 97.14%, an F1-score of 96.12%, and an AUC of 0.99. It meets\nthe World Health Organization (WHO) recommended criteria for an acceptable\nproduct: sensitivity of 95.00% or greater and specificity of 97.00% or greater\nfor testing prior SARS-CoV-2 infection in moderate to high volume scenarios.", "paper_summary_zh": "<paragraph>\u5728\u547c\u5438\u9053\u75c5\u6bd2\u7206\u767c\u7684\u65e9\u671f\u968e\u6bb5\uff0c\u4f8b\u5982\u56b4\u91cd\u6025\u6027\u547c\u5438\u9053\u75c7\u5019\u7fa4\u51a0\u72c0\u75c5\u6bd2 2 (SARS-CoV-2)\uff0c\u6709\u6548\u5229\u7528\u6709\u9650\u7684\u9f3b\u54bd\u62ed\u5b50\u9032\u884c\u5feb\u901f\u4e14\u6e96\u78ba\u7684\u7be9\u6aa2\u5c0d\u65bc\u516c\u5171\u885b\u751f\u81f3\u95dc\u91cd\u8981\u3002\u5728\u9019\u9805\u7814\u7a76\u4e2d\uff0c\u6211\u5011\u63d0\u51fa\u4e86\u4e00\u7a2e\u65b9\u6cd5\uff0c\u5c07\u8870\u6e1b\u5168\u53cd\u5c04\u5085\u7acb\u8449\u8f49\u63db\u7d05\u5916\u7dda\u5149\u8b5c (ATR-FTIR) \u8207\u9069\u61c9\u6027\u8fed\u4ee3\u52a0\u6b0a\u61f2\u7f70\u6700\u5c0f\u5e73\u65b9 (airPLS) \u9810\u8655\u7406\u6f14\u7b97\u6cd5\u548c\u901a\u9053\u6ce8\u610f\u529b\u57fa\u790e\u504f\u6700\u5c0f\u4e8c\u4e58\u4e00\u7dad\u5377\u7a4d\u795e\u7d93\u7db2\u8def (PLS-1D-CNN) \u6a21\u578b\u6574\u5408\uff0c\u53ef\u5728 10 \u5206\u9418\u5167\u6e96\u78ba\u7be9\u9078\u53d7\u611f\u67d3\u8005\u3002\u6536\u96c6\u4e86\u5169\u7d44\u9f3b\u54bd\u62ed\u5b50\u6a23\u672c\uff0c\u5206\u5225\u5305\u542b\u4f86\u81ea\u7591\u4f3c SARS-CoV-2 Omicron \u8b8a\u7570\u682a\u75c5\u4f8b\u7684 126 \u500b\u548c 112 \u500b\u6a23\u672c\uff0c\u5728\u5317\u4eac\u4f51\u5b89\u91ab\u9662\u9032\u884c\u9a57\u8b49\u3002\u7531\u65bc ATR-FTIR \u5149\u8b5c\u5c0d\u5be6\u9a57\u689d\u4ef6\u7684\u8b8a\u5316\u9ad8\u5ea6\u654f\u611f\uff0c\u9019\u53ef\u80fd\u6703\u5f71\u97ff\u5176\u54c1\u8cea\uff0c\u6211\u5011\u63d0\u51fa\u4e86\u4e00\u7a2e\u751f\u7269\u5206\u5b50\u91cd\u8981\u6027 (BMI) \u8a55\u4f30\u65b9\u6cd5\u4f86\u8a55\u4f30\u4e0d\u540c\u689d\u4ef6\u4e0b\u7684\u8a0a\u865f\u54c1\u8cea\uff0c\u4e26\u900f\u904e\u5c07 BMI \u8207 PLS-GBM \u548c PLS-RF \u7d50\u679c\u9032\u884c\u6bd4\u8f03\u4f86\u9a57\u8b49\u3002\u5c0d\u65bc\u5728\u7b2c 2 \u7d44\u4e2d\u8868\u73fe\u51fa\u8f03\u9ad8 BMI \u7684 ATR-FTIR \u8a0a\u865f\uff0c\u6211\u5011\u5229\u7528 airPLS \u9032\u884c\u8a0a\u865f\u9810\u8655\u7406\uff0c\u7136\u5f8c\u61c9\u7528\u57fa\u65bc\u901a\u9053\u6ce8\u610f\u529b\u7684 PLS-1D-CNN \u6a21\u578b\u9032\u884c\u7be9\u9078\u3002\u5be6\u9a57\u7d50\u679c\u8868\u660e\uff0c\u6211\u5011\u7684\u6a21\u578b\u512a\u65bc\u547c\u5438\u9053\u75c5\u6bd2\u5149\u8b5c\u6aa2\u6e2c\u9818\u57df\u6700\u8fd1\u5831\u544a\u7684\u65b9\u6cd5\uff0c\u5be6\u73fe\u4e86 96.48% \u7684\u8b58\u5225\u7be9\u9078\u6e96\u78ba\u7387\u300196.24% \u7684\u9748\u654f\u5ea6\u300197.14% \u7684\u7279\u7570\u6027\u300196.12% \u7684 F1 \u5206\u6578\u548c 0.99 \u7684 AUC\u3002\u5b83\u7b26\u5408\u4e16\u754c\u885b\u751f\u7d44\u7e54 (WHO) \u63a8\u85a6\u7684\u53ef\u7528\u7522\u54c1\u6a19\u6e96\uff1a\u5728\u4e2d\u9ad8\u91cf\u5834\u666f\u4e2d\u6e2c\u8a66\u5148\u524d SARS-CoV-2 \u611f\u67d3\u6642\uff0c\u9748\u654f\u5ea6\u70ba 95.00% \u6216\u66f4\u9ad8\uff0c\u7279\u7570\u6027\u70ba 97.00% \u6216\u66f4\u9ad8\u3002</paragraph>", "author": "Wenwen Zhang et.al.", "authors": "Wenwen Zhang, Zhouzhuo Tang, Yingmei Feng, Xia Yu, Qi Jie Wang, Zhiping Lin", "id": "2410.20132v1", "paper_url": "http://arxiv.org/abs/2410.20132v1", "repo": "null"}}